The investment marks a significant milestone in Perelel's evolution from premier prenatal brand to comprehensive women's health company.WHO: Perelel is revolutionizing women's health through targeted nutrition. Founded by an OB/GYN in 2020, the brand offers research-backed vitamin routines and simplified daily wellness essentials tailored to key chapters of a woman's hormonal journey—from preconception to perimenopause. Built on a foundation of clinical expertise and uncompromising quality, Perelel is the trusted leader in fertility, pregnancy, and postpartum nutrition—while also supporting stage-specific, whole-body health, breaking the one-size-fits-all model that has dominated the category for decades. WHY: This proactive funding opportunity will replace early angel investors with a partner who will support the brand in its next stage of growth. IN THEIR OWN WORDS: "This moment validates what we've built over the past five years: a business that proves women trust and return to brands that invest in clinical rigor and medically backed solutions," said Victoria Thain Gioia, co-founder and CEO of Perelel and mother of four. "As a women-founded firm with deep expertise in scaling consumer health and wellness brands, Prelude Growth understands both our market and our mission. Their proven ability to build category leaders makes them the ideal partner as we evolve beyond pregnancy and postpartum support into a comprehensive women's health company. We're so excited to add them to our bench of incredible female board members.